These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Ustekinumab in a patient with pyoderma gangrenosum and refractory Crohn's disease. García Cámara P; Zubiri Ara ML; García López S Med Clin (Barc); 2019 Oct; 153(8):e35-e36. PubMed ID: 30795905 [No Abstract] [Full Text] [Related]
13. Pyoderma gangrenosum in an infant: A case report and review of the literature. Crouse L; McShane D; Morrell DS; Wu EY Pediatr Dermatol; 2018 Sep; 35(5):e257-e261. PubMed ID: 29656404 [TBL] [Abstract][Full Text] [Related]
14. [Infliximab for a girl with refractory pyoderma gangrenosum]. Nozawa T; Hara R; Kinoshita J; Sano F; Miyamae T; Imagawa T; Mori M; Hirokado M; Takahashi K; Inayama Y; Yokota S Nihon Rinsho Meneki Gakkai Kaishi; 2008 Dec; 31(6):454-9. PubMed ID: 19122376 [TBL] [Abstract][Full Text] [Related]
15. Dramatic improvement of pyoderma gangrenosum with infliximab in a patient with PAPA syndrome. Stichweh DS; Punaro M; Pascual V Pediatr Dermatol; 2005; 22(3):262-5. PubMed ID: 15916580 [TBL] [Abstract][Full Text] [Related]
16. Treatment of pyoderma gangrenosum with methotrexate. Teitel AD Cutis; 1996 May; 57(5):326-8. PubMed ID: 8726713 [TBL] [Abstract][Full Text] [Related]
17. When is recalcitrant pyoderma gangrenosum truly recalcitrant? Barnabé C; Hurst L; Alowami S J Cutan Med Surg; 2003; 7(5):387-9. PubMed ID: 14758523 [TBL] [Abstract][Full Text] [Related]